Camber Pharmaceuticals Inc recalls

8 recalls on record · latest: March 13, 2023

Official U.S. recall history for Camber Pharmaceuticals Inc, compiled from official government records.

Get recall alerts

Free email alert whenever Camber Pharmaceuticals Inc has a new recall — straight from official government data. Unsubscribe anytime.

Atovaquone Oral Suspension USP recalled over sterility concerns

March 13, 2023 · Drug & medication recalls High risk Microbial Contamination of Non-Sterile Product: Objectionable organism, identif…

Camber Pharmaceuticals, Inc recalls Lacosamide Oral Solution, USP, CV, 10mg/mL, packaged in 200 mL bottle, Rx Only, Manufactured for: Camber Pharmaceutical…

December 6, 2022 · Drug & medication recalls Failed Excipient Specifications: out of specification result observed for p-Hyd…

Valsartan Tablets recalled over foreign material

March 20, 2020 · Drug & medication recalls Detection of Trace Amounts of N-Nitrosodimethylamine (NDMA) Impurity — Potentia…

Losartan Potassium Tablets USP recalled over manufacturing violations

February 28, 2019 · Drug & medication recalls Moderate risk CGMP Deviations; trace amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA…

Losartan Potassium Tablets USP recalled over manufacturing violations

February 28, 2019 · Drug & medication recalls Moderate risk CGMP Deviations; trace amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA…

Losartan Potassium Tablets USP recalled over manufacturing violations

February 28, 2019 · Drug & medication recalls Moderate risk CGMP Deviations; trace amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA…

Camber Pharmaceuticals, Inc. recalls Camber Pharmaceuticals, Inc. — Losartan Tablets USP 25 mg, 50 mg, and 100 mg

February 28, 2019 · Drug & medication recalls Due to The Detection of N-Nitroso N-Methyl 4-Amino Butyric Acid (NMBA) — Unappr…

Montelukast Sodium Tablets recalled over labeling errors

September 7, 2018 · Drug & medication recalls Mislabeling — Mislabeling